Oxford BioMedica AMSCI Project

Practical completion has been achieved for Phase 1 of this renovation and extension of Oxford BioMedica's facility for cell therapy research, development, and manufacturing.

Abell Nepp provided full architectural and lead consultancy services on the project which forms part of a phased redevelopment of the site. It includes a new suite of GMP ISO 5, Class 100 clean rooms.

Oxford BioMedica are a spin-out company of Oxford University. The project was supported by Finance Birmingham's AMSCI programme which provided a grant for the project.

Principal Contractor: Walter Lilly

Phase 1 Construction Cost: £5m

March 2016